This firm was established in 2005 to provide intellectual property services to start-up, mid-stage and large commercial organizations and universities in the life sciences industry.  The firm continually strives to develop a network of research experts, consultants, legal service providers, and investors from which our clients may benefit.  Our goal is to combine the traditional functions of intellectual property law firms and strategic consulting organizations to assist clients in achieving their objectives.  The intellectual property services provided include patent and trademark prosecution, new product / acquisition target analysis, patentability and freedom-to-operate opinions, patent and license portfolio evaluation, license negotiation and drafting, and paragraph IV / Hatch-Waxman-related strategic planning.

Pat began his intellectual property career as a scientific advisor in 1996 at Banner & Witcoff, Ltd. and soon thereafter joined McDonnell, Boehnen, Hulbert & Berghoff, LLP.  In 1997, Pat obtained his registration to practice before the United States Patent and Trademark Office (Reg. No. 41,053).  He graduated from Chicago-Kent College of Law in 1999 and was admitted to practice law in the State of Illinois.  As an associate, Pat counseled large, mid-size, and start-up pharmaceutical and biotechnology companies, universities, as well as investment groups on a variety of intellectual property issues.  In 2001, Pat joined Aventis Pasteur, Inc. (now Sanofi Pasteur, Inc.), eventually becoming Senior Director of Intellectual Property.  In that role, he was responsible for domestic and international intellectual property issues relating to various projects within the company.  Throughout his career, Pat has worked extensively with outside counsel from other regions and countries including Australia, Europe, Canada, China, India, Japan, and New Zealand.

Pat earned a Ph.D. in Microbiology and Immunology from The University of Health Sciences / The Chicago Medical School (now the Rosalind Franklin Institute (North Chicago, IL) (1994)).  His doctoral project related to the biochemical characterization and cloning of the cDNA encoding a porcine cytolytic trigger molecule which was identified as an Fc-g receptor (e.g., Halloran, et al.  J. Immunol. 153(6): 2631-41 (Sept. 15, 1994) and Halloran, et al. Cell. Immunol. 158(2): 400-13 (Oct. 15, 1994)).  During his graduate studies, Pat served as Secretary (1989), Vice-President (1990), and President (1991-1993) of the Graduate Student Association and won first place in the 1994 Sigma Xi Research Society research competiton ("Identification of the Porcine Cytolytic Trigger Molecule G7 as an Fc-g receptor").  Pat also performed post-doctoral studies at The National Cancer Institute (Frederick, MD) from 1994-1996 relating to novel approaches for gene therapy of melanoma (Siders, et al. Cancer Res. 56(24): 5638-46 (Dec. 15, 1996); Halloran, et al. Cancer Res. 58(17): 3855-65 (Sept. 1, 1998); and, Siders et al. Cancer Gene Ther. 5(5): 281-91 (Sept.-Oct. 1998)).  He also has a B.A. in Biology from Augustana College (Rock Island, IL; 1989) where he was a member of the Beta Beta Beta Biological Honor Society, the Educational Policies Committee, and two NCAA Division III National Championship football teams.

Please do not hesitate to contact us at 610-984-4751 or pat@pathalloran.com.

You may also view Pat's profile at http://www.linkedin.com/in/pathalloran.

Memberships and Associations:  American Bar Association, American Intellectual Property Law Association, American Chemical Society, Federal Circuit Bar Association, Illinois State Bar Association, Licensing Executives Society